Who owns Nuvectis Pharma, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of NVCT from SEC Form 13F filings across 82 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 82 institutions disclosed 10.2M shares of Nuvectis Pharma, Inc. worth $189.0M — about 43.6% of shares outstanding; the largest disclosed holder is TANG CAPITAL MANAGEMENT LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
82
13F holders
$189.0M
value, 2026 filers
43.6%
of shares outstanding (10.2M sh)
29
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of NVCT's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | TANG CAPITAL MANAGEMENT LLCNEW | 1.6M | $28.5M | 1.3% | 6.6% | new |
| 2 | BlackRock, Inc. | 1.0M | $18.4M | 0.0% | 4.3% | +31.0% |
| 3 | Soleus Capital Management, L.P.NEW | 1.0M | $18.4M | 0.6% | 4.3% | new |
| 4 | PERCEPTIVE ADVISORS LLCNEW | 1.0M | $18.4M | 0.3% | 4.3% | new |
| 5 | VANGUARD CAPITAL MANAGEMENT LLC | 872,482 | $16.0M | 0.0% | 3.7% | +32.2% |
| 6 | IRIDIAN ASSET MANAGEMENT LLC/CT | 777,078 | $14.3M | 4.9% | 3.3% | +19.2% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 432,273 | $8.0M | 0.0% | 1.8% | +12.5% |
| 8 | SPHERA FUNDS MANAGEMENT LTD.NEW | 382,945 | $7.0M | 0.9% | 1.6% | new |
| 9 | BALDWIN WEALTH PARTNERS LLC/MA | 382,015 | $7.0M | 0.5% | 1.6% | +0.9% |
| 10 | Occam Crest Management LP | 357,147 | $7.4M | 3.8% | 1.5% | -12.3% |
| 11 | Alyeska Investment Group, L.P.NEW | 275,000 | $5.1M | 0.0% | 1.2% | new |
| 12 | STATE STREET CORP | 248,198 | $4.6M | 0.0% | 1.1% | +49.1% |
| 13 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 217,286 | $4.0M | 0.0% | 0.9% | +106.4% |
| 14 | Avidity Partners Management LPNEW | 200,000 | $3.7M | 0.6% | 0.9% | new |
| 15 | NORTHERN TRUST CORP | 146,714 | $2.7M | 0.0% | 0.6% | +18.1% |
| 16 | VANGUARD FIDUCIARY TRUST CO | 127,554 | $2.3M | 0.0% | 0.5% | +11.1% |
| 17 | VANGUARD PORTFOLIO MANAGEMENT LLC | 118,297 | $2.2M | 0.0% | 0.5% | +28.4% |
| 18 | CITADEL ADVISORS LLC | 115,532 | $2.1M | 0.0% | 0.5% | +47.3% |
| 19 | Kalehua Capital Management LLCNEW | 100,000 | $1.8M | 1.3% | 0.4% | new |
| 20 | OPPENHEIMER & CO INC | 73,566 | $1.4M | 0.0% | 0.3% | 0.0% |
| 21 | UBS Group AG | 69,200 | $1.3M | 0.0% | 0.3% | +79.4% |
| 22 | CIBC Bancorp USA Inc. | 67,155 | $917,661 | 0.0% | 0.3% | +161.7% |
| 23 | FORBES J M & CO LLPNEW | 59,000 | $1.1M | 0.1% | 0.3% | new |
| 24 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 57,133 | $1.1M | 0.0% | 0.2% | +15.1% |
| 25 | Informed Momentum Co LLCNEW | 47,168 | $867,420 | 0.1% | 0.2% | new |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.